It is a little-known fact that the National Institutes of Health, NIH and the National Institute of Allergy and Infectious Diseases, NIAID announced the establishment of the Centers for Research in Emerging Infectious Diseases (CREID) in August 2020, smack dab in the middle of the COVID-19 pandemic. The network promised to set up a worldwide surveillance architecture to identify the next pandemic pathogen before it moves from animal to human.
Anthony Fauci justified the addition of the new “global network” to the NIH/NIAID portfolio as yet another way to “enable early warnings of emerging diseases,” which is, he added, “critical to rapid responses” and will “increase our preparedness for future outbreaks.” Sounds about right for Fauci—however, his words ring hollow, given his management of the pandemic was nothing short of disastrous. Knowing what we know now, this partnership will probably be another way to develop more “safe and effective” vaccines or share our precious intellectual property with the CCP.
According to the press release, the first-year value of the 11 awarded grants totaled approximately $17 million. The NIH announcement states, “NIAID intends to provide approximately $82 million over five years to support the network.” Round three of CREID applications for grants were launched in September 2022 for FY2023.
The CREID Network Pilot Research Program supports, trains, and mentors the next generation of #emerginginfectiousdisease researchers. The 2023 Call for Applications will be released September 1, 2022. https://t.co/kB21fXDtMb pic.twitter.com/toW3cXpLWD
— NIAID-CREID (@CREID_Network) July 29, 2022
Click here to read the full article